Clinical trial
Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
NCT00420277 · Sangart, Industry · Completed
Key facts
| NCT number | NCT00420277 |
|---|---|
| Title | Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty |
| Official title | A Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of an Oxygen-Carrying Plasma Expander, Hemospan®, Compared With Voluven® toTreat Hypotension in Patients Undergoing Primary Hip Arthroplasty With Spinal Anesthesia |
| Lead sponsor | Sangart, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypotension, Ischemia |
| Intervention type | Drug |
| Interventions | Hemospan (MP4OX), Voluven (HES 130/0.4) |
| Enrollment | 462 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jan 11, 2007 |
| Last update posted | Aug 19, 2013 |
| Countries | Belgium, Czechia, Netherlands, Poland, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: